Acurx Pharmaceuticals LLC (ACXP)

Name: Acurx Pharmaceuticals LLC (ACXP) Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: Acurx Pharmaceuticals LLC (ACXP)

Stock Card

$1.46

$0.03 (2.10%)

As on 27-Aug-2026 16:00EDT

Market cap

$6 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

P/B Ratio

0.8

Div. Yield

0 %

Acurx Pharmaceuticals LLC (ACXP) Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 1.42 High: 1.48

52 Week Range

Low: 1.31 High: 8.34

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$0 Mln
ROE

-1.3 %
ROCE

-- %
Industry P/E

--
EV/EBITDA

-3.5
Debt to Equity

0
Book Value

$--
EPS

$-3.9
Face value

--
Shares outstanding

4,297,738

5 Years Aggregate

CFO

$-29.69 Mln

EBITDA

$-50.02 Mln

Net Profit

$-49.88 Mln

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
Acurx Pharmaceuticals LLC (ACXP)	-41.4	2.8	-24.7	-71.4	-66.1	-57.0	--
BSE Sensex^*	-8.9	0.3	1.6	-4.6	5.9	6.6	10.7
S&P Small-Cap 600^#	-5.8	-5.3	-13.7	-6.3	5.3	3.0	5.5

As on 27-Aug-2026 | *As on 28-Aug-2026 | #As on 26-Oct-2023

Company	2025	2024	2023	2022
Acurx Pharmaceuticals LLC (ACXP)	-84.7	-78.5	-3.8	-7.9
S&P Small-Cap 600	4.0	7.0	13.9	-17.4
BSE Sensex	9.1	8.1	18.7	4.4

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Peers

View Details

Company	Price ($)	Market Cap ($ Mln)	Revenue (TTM)	Net Profit (TTM)	OPM (%)	ROE (%)	P/E	P/B
Acurx Pharmaceuticals LLC (ACXP)	1.5	6.3	0.0	-7.5	--	-111.9	--	0.8
Arrowhead Pharmaceuticals (ARWR)	88.6	12,304.7	669.5	-320.0	-0.8	-71.1	--	26.4
Cytokinetics Inc (CYTK)	77.9	10,682.6	71.0	-894.0	-1,175.8	--	--	60.3
Exelixis (EXEL)	55.3	13,400.0	2,435.9	860.6	31.0	43	17	7.3
Halozyme Therapeutics (HALO)	106.9	12,277.1	1,663.7	413.6	36.3	430	31.2	83.9
Krystal Biotech (KRYS)	357.5	10,258.4	440.5	241.5	33.4	18.7	42.2	7.3
Madrigal Pharmaceuticals (MDGL)	543.7	11,938.8	1,283.9	-325.1	-19.0	-57.7	--	22.9
Medpace Holdings (MEDP)	611.6	17,326.2	2,782.3	491.5	21.1	110.1	36.5	39.4
Praxis Precision MedicinesÂ Inc (PRAX)	367.9	10,496.2	0.0	-339.1	--	-30.6	--	7.6
Protagonist Therapeutics (PTGX)	149.5	9,985.8	282.0	82.9	-28.6	11.4	147	11.6

Shareholding Pattern

View Details

About Acurx Pharmaceuticals LLC (ACXP)

Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections in the United States. The company's lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the... polymerase IIIC enzyme that is in Phase 2b clinical trial to treat patients with clostridium difficile infections. It also develops ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus (MRSA), vancomycin resistant enterococcus (VRE), and drug-resistant streptococcus pneumoniae (DRSP), as well as B. anthracis. Acurx Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Staten Island, New York. Read more

Co-Founder & Executive Chairman

Mr. Robert J. DeLuccia
Co-Founder & Executive Chairman

Mr. Robert J. DeLuccia
Headquarters

Staten Island, NY
Website

https://www.acurxpharma.com

FAQs for Acurx Pharmaceuticals LLC (ACXP)

What is the current share price of Acurx Pharmaceuticals LLC (ACXP) Today?

The share price of Acurx Pharmaceuticals LLC (ACXP) is $1.46 (NASDAQ) as of 27-Aug-2026 16:00 EDT. Acurx Pharmaceuticals LLC (ACXP) has given a return of -66.08% in the last 3 years.

What is the current PB & PE ratio of Acurx Pharmaceuticals LLC (ACXP)?

Since, TTM earnings of Acurx Pharmaceuticals LLC (ACXP) is negative, P/E ratio is not available.
The P/B ratio of Acurx Pharmaceuticals LLC (ACXP) is 0.76 times as on 21-Aug-2026, a 86 discount to its peers’ median range of 5.35 times.

PE & PB ratio at the end of financial year.

Year	P/E Ratio	P/B Ratio
2025	-0.47	0.71
2024	-0.05	1.13
2023	-0.18	0.55
2022	-0.19	0.32
2021	-0.17	0.18

What is the 52 Week High and Low of Acurx Pharmaceuticals LLC (ACXP)?

The 52-week high and low of Acurx Pharmaceuticals LLC (ACXP) are Rs 8.34 and Rs 1.31 as of 28-Aug-2026.

What is the market cap of Acurx Pharmaceuticals LLC (ACXP)?

Acurx Pharmaceuticals LLC (ACXP) has a market capitalisation of $ 6 Mln as on 21-Aug-2026. As per SEBI classification, it is a Small Cap company.

Should I invest in Acurx Pharmaceuticals LLC (ACXP)?

Before investing in Acurx Pharmaceuticals LLC (ACXP), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.

Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.